As published in CK Momentum Issue 9 (Click here to download)
John Toigo and Kate Gardner in our Corporate Team, recently acted as the Australian lawyers for Anteo Diagnostics Limited (ASX:ADO), an Australian listed
biotech company, in its acquisition of 100% of DIAsource ImmunoAssays S.A., a Belgium based diagnostics company, which operates in 75 countries.
This is a transformational acquisition for Anteo, providing it with an established global distribution platform, manufacturing capabilities and a significantly
broadened product range. As part of this transaction John and Kate also advised Anteo on its capital raising activities (including a rights issue)
to fund the acquisition.
ClarkeKann is a commercial law firm in Sydney. Our expertise covers commercial & corporate transactions, financial services, litigation, risk management
and insolvency, property transactions and resources projects, across a range of industries. For a full list of our legal services, please visit our website
. To update your contact details or unsubscribe to any of our publications, email us
This bulletin is produced as general information in summary for clients and subscribers and should not be relied upon as a substitute for detailed legal
advice or as a basis for formulating business or other decisions. ClarkeKann asserts copyright over the contents of this document. This bulletin is
produced by ClarkeKann. It is intended to provide general information in summary form on legal topics, current at the time of publication. The contents
do not constitute legal advice and should not be relied upon as such. Formal legal advice should be sought in particular matters. Liability limited